Quantcast

Latest Sunovion Stories

2014-07-15 08:27:41

WILMINGTON, Mass., July 15, 2014 /PRNewswire/ -- CutisPharma announced today that it has appointed Neal Muni, MD, MSPH as President and member of the Board of Directors. Dr. Muni will assume responsibility for overseeing the company's commercial operations and guiding development strategy for its product portfolio. "We are pleased that Neal has joined our team to take our company to the next level of growth and continue our leading position as an innovator in pharmaceutical...

2014-07-11 08:24:53

MISSISSAUGA, ON, July 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today announced that Health Canada approved APTIOM(TM) (eslicarbazepine acetate) for use as a once-daily adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy who are not satisfactorily controlled with conventional therapy. APTIOM(TM) is not indicated for use in patients under 18 years of age. Epilepsy is one of the most common neurological disorders and...

2014-06-10 08:30:11

NASDAQ: CRME TSX: COM VANCOUVER, June 10, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that pursuant to the increase in size of the Board of Directors to six members, as disclosed in the 2014 information circular, an additional director nominee will be included at its 2014 Annual General and Special Meeting of Shareholders held on June 16, 2014. The Company is pleased to announce the nomination of W. James O'Shea to the Board of...

2014-04-15 12:29:59

PITTSBURGH, April 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Eszopiclone Tablets 1 mg, 2 mg and 3 mg, the generic version of Sunovion Pharmaceuticals Inc.'s Lunesta(®). Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of insomnia. Eszopiclone Tablets 1 mg, 2 mg, 3 mg had U.S. sales of approximately $851.8...

2014-03-19 16:23:40

ALISO VIEJO, Calif., March 19, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Dr. Mark Corrigan to the company's board of directors. Dr. Corrigan, a seasoned life sciences executive joins Avanir's board with broad healthcare industry experience. http://photos.prnewswire.com/prnvar/20130207/LA55901LOGO Dr. Corrigan currently serves as president and chief executive officer of Zalicus Inc. a public biopharmaceutical company, a...

2013-10-14 23:20:31

Reportbuyer.com just published a new market research report: Global Pulmonary Drug Delivery Systems Market 2012-2016. London (PRWEB) October 14, 2013 TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related